Daniel A Shelly
Seminars
Wednesday 3rd December 2025
Panel Discussion: Comparing Immune Cell Depletion & Immune Tolerance Therapies to Accelerate Safer, Efficacious Therapies
1:40 pm
- Expand therapeutic approaches beyond B-cell depletion
- Highlight safety challenges with depletion in comparison to tolerance with Tregs
- Explore the long-term biological effects of B-cell depletion and immune reprogramming therapies
Thursday 4th December 2025
Driving Innovation Through Treg Data & Antigen Targeting to Unlock Treg Therapeutic Potential
3:45 pm
- Utilize polyclonal Treg data to guide therapeutic direction and inform next-generation cell therapy design
- Highlight PolTREG and Immuthera’s latest Type 1 Diabetes findings to demonstrate clinical progress and therapeutic potential
- Advance disease-specific Treg therapies by leveraging antigen-driven precision for durable immune modulation
